Last reviewed · How we verify
AG019 - Low Dose
At a glance
| Generic name | AG019 - Low Dose |
|---|---|
| Sponsor | Precigen Actobio T1D, LLC |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
- Dyspepsia
- Anaemia
- Eosinophilia
- Erythropenia
- Iron deficiency anaemia
- Leukopenia
- Lymphadenopathy
- Lymphopenia
- Microcytic anaemia
- Neutropenia
- Palpitations
- Sinus bradycardia
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |